Depression alert in Asian COPD patients

Data from Taiwan indicate that patients with chronic obstructive pulmonary disease (COPD) are nearly twice as likely as other patients to develop depression.

Researchers Fung-Chang Sung (China Medical University, Taichung, Taiwan) and colleagues found that the risk was particularly high within the year following COPD diagnosis and then declined over time.

Noting that the stigma around mental illness may prevent Asian patients from openly discussing symptoms of depression, they say: “The need to routinely screen COPD patients for depression and institute culturally appropriate interventions should be emphasized, especially within the first year since COPD diagnosis.”

The team analyzed national insurance database data, identifying 38,010 COPD patients who were diagnosed between 2000 and 2004, and an equal number of age- and gender-matched controls.

By the end of 2008, 4109 patients overall had been newly diagnosed with depression. In multivariate analysis, those with COPD were 88% more likely to have depression, at a rate of 12.2 per 1000 person–years compared with 6.5 per 1000 person–years among controls.

The team notes that the risk for depression fell with time since COPD diagnosis from a 2.01-fold increased risk in the subsequent year to a 1.40-fold increased risk after year 5.

Women were at particular risk for depression during follow-up, being 1.19-fold more likely to develop it than men. Additionally, being younger, having a lower monthly income, and being hospitalized were all associated with the likelihood for depression, as were certain comorbidities, including heart disease, arthritis, cancer, and hypertension.

“These findings suggest that healthcare providers need to pay closer attention to newly diagnosed patients with COPD, particularly inpatients,” Sung and colleagues write in BMC Public Health.

They say that their findings reflect those previously reported in Western populations and add to scant information on the presence of depression among Asian COPD patients, who they say may find it a particularly embarrassing condition to seek treatment for.

“Therefore, the implementation of a standardized care process, including some screening tools applicable to COPD patients, may be of utmost importance,” they conclude.

Licensed from medwireNews with permission from Springer Healthcare Ltd. ©Springer Healthcare Ltd. All rights reserved. Neither of these parties endorse or recommend any commercial products, services, or equipment.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study suggests beta-blockers may elevate depression symptoms in post-MI patients